Global Clinical Trial Supplies Market 2018-2022

治験用品の世界市場2018-2022:医療機器、生物製剤、医薬品

◆タイトル:Global Clinical Trial Supplies Market 2018-2022
◆商品コード:IRTNTR20632
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年2月28日
◆ページ数:129
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、治験用品の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、治験用品の世界市場規模及び予測、需要先別分析、地域別分析/市場規模、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。

・エグゼクティブサマリー
・治験用品の世界市場:市場概観
・治験用品の世界市場:業界の構造分析
・治験用品の世界市場:市場規模及び予測
・治験用品の世界市場:需要先別分析
・治験用品の世界市場:地域別分析
・治験用品の世界市場:ヨーロッパ市場規模
・治験用品の世界市場:主要国別分析
・治験用品の世界市場:成長要因
・治験用品の世界市場:課題
・治験用品の世界市場:市場動向
・治験用品の世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

This industry research report presents a comprehensive analysis of the clinical trial supplies market by end-user based on pharmaceutical industry, biologics industry, medical device industry. The report also provides an analysis of the market based on geographic regions such as the Americas, APAC, and EMEA.Our market research analysts predict that this market will grow at a CAGR of more than 8% by 2022.
Key questions answered in the report include
• What will the market size and the growth rate be in 2022?
• What are the key factors driving the global clinical trial supplies market?
• What are the key market trends impacting the growth of the global clinical trial supplies market?
• What are the challenges to market growth?
• Who are the key vendors in the global clinical trial supplies market?
• What are the market opportunities and threats faced by the vendors in the global clinical trial supplies market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global clinical trial supplies market?

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Medical device industry
• Biologics industry
• Pharmaceutical industry
• Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Growing demand of CROs
• Increase in studies focusing on pharmaceutical industry
• Rising demand of e-clinical trials

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Almac Group
• DHL
• PAREXEL International
• Thermo Fisher Scientific
• UPS
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition – Inclusions and exclusions checklist
Exhibit 05: Validation techniques employed for market sizing 2017
Exhibit 06: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 07: Global – Year-over-year growth 2018-2022 (%)
Exhibit 08: Five forces analysis 2017
Exhibit 09: Five forces analysis 2022
Exhibit 10: Bargaining power of buyers
Exhibit 11: Bargaining power of suppliers
Exhibit 12: Threat of new entrants
Exhibit 13: Threat of substitutes
Exhibit 14: Threat of rivalry
Exhibit 15: Market condition – Five forces 2017-2022
Exhibit 16: Customer landscape
Exhibit 17: End-user – Market share 2017-2022 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Medical device industry – Market size and forecast 2017-2022 ($ mn)
Exhibit 20: Medical device industry – Year-over-year growth 2018-2022 (%)
Exhibit 21: Biologics industry – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Biologics industry – Year-over-year growth 2018-2022 (%)
Exhibit 23: Pharmaceutical industry – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Pharmaceutical industry – Year-over-year growth 2018-2022 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Global – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Medical technology industry including IVD market in Europe in 2014
Exhibit 32: Growth of healthcare application in Europe in 2014 (% CAGR)
Exhibit 33: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Vendor overview
Exhibit 46: Almac Group – Business segments
Exhibit 47: Almac Group – Organizational developments
Exhibit 48: Almac Group – Geographic focus
Exhibit 49: Almac Group – Segment focus
Exhibit 50: Almac Group – Key offerings
Exhibit 51: Vendor overview
Exhibit 52: DHL – Business segments
Exhibit 53: DHL – Organizational developments
Exhibit 54: DHL – Geographic focus
Exhibit 55: DHL – Segment focus
Exhibit 56: DHL – Key offerings
Exhibit 57: Vendor overview
Exhibit 58: PAREXEL International – Business segments
Exhibit 59: PAREXEL International – Organizational developments
Exhibit 60: PAREXEL International – Geographic focus
Exhibit 61: PAREXEL International – Segment focus
Exhibit 62: PAREXEL International – Key offerings
Exhibit 63: Vendor overview
Note: Fisher Clinical service is a part of Biopharma Services Division of Thermo Fisher Scientific and operates as an independent company. In business segments, the business offerings of fisher clinical services are included.
Exhibit 64: Thermo Fisher Scientific – Business segments
Exhibit 65: Thermo Fisher Scientific – Organizational developments
Exhibit 66: Thermo Fisher Scientific – Geographic focus
Exhibit 67: Thermo Fisher Scientific – Segment focus
Exhibit 68: Thermo Fisher Scientific – Key offerings
Exhibit 69: Vendor overview
Exhibit 70: UPS – Business segments
Exhibit 71: UPS – Organizational developments
Exhibit 72: UPS – Geographic focus
Exhibit 73: UPS – Segment focus
Exhibit 74: UPS – Key offerings



【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[治験用品の世界市場2018-2022:医療機器、生物製剤、医薬品]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆